×
Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES) PDF
$ 40.00
Detection of Subclinical Depression in Bipolar Disorder: A Cross-Sectional, 4-Month Prospective Follow-Up Study at Community Mental Health Services (SIN-DEPRES) PDF quantity
$ 40.00
×
Becoming the Center of Attention in Social Anxiety Disorder: Startle Reactivity to a Virtual Audience During Speech Anticipation PDF
$ 40.00
Becoming the Center of Attention in Social Anxiety Disorder: Startle Reactivity to a Virtual Audience During Speech Anticipation PDF quantity
$ 40.00
×
Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Decisional Capacity to Consent to Research Among Patients With Bipolar Disorder: Comparison With Schizophrenia Patients and Healthy Subjects PDF
$ 40.00
Decisional Capacity to Consent to Research Among Patients With Bipolar Disorder: Comparison With Schizophrenia Patients and Healthy Subjects PDF quantity
$ 40.00
×
De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF
$ 40.00
De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart